What is the equity of Abbvie this year?
Abbvie has equity of 10.36 B USD this year.
Abbvie Equity 2024
Abbvie Equity
10.36 B USD
Abbvie Dividend yield
3.6 %
Ticker
ABBV
ISIN
US00287Y1091
WKN
A1J84E
In 2024, Abbvie's equity was 10.36 B USD, a -39.96% increase from the 17.25 B USD equity in the previous year.
Abbvie Aktienanalyse
What does Abbvie do?
Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. Abbvie ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Abbvie's Equity
Abbvie's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Abbvie's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Abbvie's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Abbvie's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Abbvie’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Abbvie Stock
What was the equity of Abbvie compared to the previous year?
The equity of Abbvie has increased/decreased by -39.96% decreased compared to the previous year.
What impact does a high equity have on investors of Abbvie?
A high equity is advantageous for investors of Abbvie as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Abbvie?
A low equity can be a risk for investors of Abbvie, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Abbvie affect the company?
An increase in equity of Abbvie can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Abbvie affect the company?
A reduction in equity of Abbvie can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Abbvie?
Some factors that can affect the equity of Abbvie include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Abbvie so important for investors?
The equity of Abbvie is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Abbvie take to change the equity?
To change equity, Abbvie can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Abbvie pay?
Over the past 12 months, Abbvie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.6 %. For the coming 12 months, Abbvie is expected to pay a dividend of 6.04 USD.
What is the dividend yield of Abbvie?
The current dividend yield of Abbvie is 3.6 %.
When does Abbvie pay dividends?
Abbvie pays a quarterly dividend. This is distributed in the months of August, November, February, May.
How secure is the dividend of Abbvie?
Abbvie paid dividends every year for the past 101 years.
What is the dividend of Abbvie?
For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.68 %.
In which sector is Abbvie located?
Abbvie is assigned to the 'Health' sector.
Wann musste ich die Aktien von Abbvie kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Abbvie from 5/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.
When did Abbvie pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Abbvie in the year 2023?
In the year 2023, Abbvie distributed 5.64 USD as dividends.
In which currency does Abbvie pay out the dividend?
The dividends of Abbvie are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Abbvie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Abbvie
Our stock analysis for Abbvie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbvie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
